Did you respond to the wrong post? I didn’t say anything negative about the potential here, and I’ve been invested here for a LONG time.
On the OTC, and most specifically with startup biotech, I’ve just seen those price points repeat on charts quite often. And in fact have done quite well trading those inflection points.
If the initial Covid data proves out, sky is the limit given present global concern. Otherwise, even with just what we know about B so far, and K always in th wings, I still believe we see $20+ regardless.
But that is just my opinion, and why I’ve held on to my shares over the years.